文献速递功能神经外科

丘脑中央中核脑深部电刺激治疗耐药性癫痫:单中心经验

Centromedian thalamic deep brain stimulation for drug-resistant epilepsy: single-center experience.
PubMed 文献 · J Neurosurg · 2022-04-08

该单中心回顾性研究纳入2018年12月至2021年5月在埃默里大学接受丘脑中央中核脑深部电刺激的14例耐药性癫痫患者,末次随访(平均19±5个月)时中位癫痫发作频率降低91%,12例(86%)为应答者,手术不良事件罕见。作者认为丘脑中央中核脑深部电刺激对耐药性全面性和双额叶癫痫有效。

要点

  • 14例耐药性癫痫患者接受丘脑中央中核脑深部电刺激,末次随访中位发作频率降低91%。
  • 12例(86%)为应答者(发作频率降低≥50%),包括12例全面性癫痫中的10例和2例双额叶癫痫。
  • 手术不良事件罕见:1例硬件断裂、1例术后误吸事件、1例无临床意义的颅内出血。

核心结论

  • 丘脑中央中核脑深部电刺激是耐药性全面性和双额叶癫痫的有效治疗方法。
  • 作者认为需要进一步研究和分析丘脑中央中核脑深部电刺激是否最适合特定癫痫类型,以及不同癫痫中电极位置与结局的关系。

研究设计与样本

  • 回顾性病历审查,纳入2018年12月至2021年5月在埃默里大学接受丘脑中央中核脑深部电刺激的所有患者,共14例。
  • 电极植入采用三种不同手术方法:框架立体定向、机器人辅助和直接MRI引导。

主要发现

  • 14例患者中,9例为症状性全面性癫痫(包括5例Lennox-Gastaut综合征),3例为原发性或特发性全面性癫痫,2例为双额叶局灶性癫痫。
  • 末次随访(平均19±5个月,范围4.1-33个月,其中11例随访≥6个月)时,中位癫痫发作频率降低91%。
  • 12例(86%)为应答者(发作频率降低≥50%),包括12例全面性癫痫中的10例和2例双额叶癫痫患者。
  • 手术不良事件罕见,包括1例硬件断裂、1例术后误吸事件和1例无临床意义的颅内出血。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Neuromodulation of the centromedian nucleus of the thalamus (CM) has unclear effectiveness in the treatment of drug-resistant epilepsy. Prior reports suggest that it may be more effective in the generalized epilepsies such as Lennox-Gastaut syndrome (LGS). The objective of this study was to determine the outcome of CM deep brain stimulation (DBS) at the authors' institution. METHODS: Retrospective chart review was performed for all patients who underwent CM DBS at Emory University, which occurred between December 2018 and May 2021. CM DBS electrodes were implanted using three different surgical methods, including frame-based, robot-assisted, and direct MRI-guided. Seizure frequency, stimulation parameters, and adverse events were recorded from subsequent clinical follow-up visits. RESULTS: Fourteen patients underwent CM DBS: 9 had symptomatic generalized epilepsy (including 5 with LGS), 3 had primary or idiopathic generalized epilepsy, and 2 had bifrontal focal epilepsy. At last follow-up (mean [± SEM] 19 ± 5 months, range 4.1-33 months, ≥ 6 months in 11 patients), the median seizure frequency reduction was 91%. Twelve patients (86%) were considered responders (≥ 50% decrease in seizure frequency), including 10 of 12 with generalized epilepsy and both patients with bifrontal epilepsy. Surgical adverse events were rare and included 1 patient with hardware breakage, 1 with a postoperative aspiration event, and 1 with a nonclinically significant intracranial hemorrhage. CONCLUSIONS: CM DBS was an effective treatment for drug-resistant generalized and bifrontal epilepsies. Additional studies and analyses may investigate whether CM DBS is best suited for specific epilepsy types, and the relationship of lead location to outcome in different epilepsies.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Yang JC, Bullinger KL, Isbaine F, et al. Centromedian thalamic deep brain stimulation for drug-resistant epilepsy: single-center experience. J Neurosurg. 2022. PMID: 35395630. doi:10.3171/2022.2.JNS212237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。